- Splenic stiffness measurement to predict decompensation in compensated advanced chronic liver disease
- Browse: 112 Download: 344 Issue Date: 2026-09-17
- From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
- Browse: 86 Download: 269 Issue Date: 2026-09-17
- Hepatocellular carcinoma with obstructive jaundice: Biliary drainage and multimodal therapy
- Browse: 97 Download: 250 Issue Date: 2026-09-17
- Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances
- Browse: 81 Download: 255 Issue Date: 2026-09-17
- Predicting pancreatic fistula risk after splenectomy in cirrhotic splenomegaly: Surgical anatomy and implications
- Browse: 83 Download: 240 Issue Date: 2026-09-17
- Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
- Browse: 118 Download: 371 Issue Date: 2026-08-18
- Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
- Browse: 98 Download: 523 Issue Date: 2026-08-18
- Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
- Browse: 95 Download: 547 Issue Date: 2026-08-18
- Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
- Browse: 111 Download: 274 Issue Date: 2026-08-18
- Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
- Browse: 82 Download: 335 Issue Date: 2026-08-18
- Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
- Browse: 141 Download: 717 Issue Date: 2026-07-24
- Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
- Browse: 126 Download: 649 Issue Date: 2026-07-24
- Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
- Browse: 143 Download: 650 Issue Date: 2026-07-24
- Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
- Browse: 117 Download: 690 Issue Date: 2026-07-24
- Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
- Browse: 119 Download: 545 Issue Date: 2026-07-24
- Tyrosine kinase inhibitors after progression on atezolizumab-bevacizumab in advanced hepatocellular carcinoma: A systematic review and meta-analysis
- Browse: 178 Download: 749 Issue Date: 2026-06-26
- Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway
- Browse: 164 Download: 598 Issue Date: 2026-06-26
- LECT2/Tie1/Src signaling regulates the oxidative stress response in endothelial cells and liver ischemia-reperfusion injury
- Browse: 158 Download: 766 Issue Date: 2026-06-26
- Emerging treatment options for metabolic dysfunction-associated steatotic liver disease and its related liver diseases
- Browse: 198 Download: 503 Issue Date: 2026-06-26
- Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis
- Browse: 148 Download: 608 Issue Date: 2026-06-26